Cerastes gasperettii was studied by measuring rat hind-paw edema. Cerastes gasperettii venom (CgV, 3.75-240 µg/paw), heated for 30s at 97°C, caused a marked dose and time-dependent edema in rat paw. Response was maximal 2h after venom administration and ceased within 24h. Heated CgV was routinely used in our experiments at the dose of 120 µg/paw. Among all the drugs and antivenoms tested, cyproheptadine and 5-nitroindazole were the most effective in inhibiting edema formation. Aprotinin, mepyramine, dexamethasone, diclofenac, dipyridamole, N ω -nitro-L-arginine, quinacrine, and nordihydroguaiaretic acid showed statistically (p<0.001) significant inhibitory effect, but with variations in their inhibition degree.
INTRODUCTION
The Kingdom of Saudi Arabia and surrounding areas are inhabited by several venomous snakes of medical importance. Among them are the families Elapidae, Hydrophiidae, Viperidae and Atractaspididae, in addition to the innocuous family Colubridae, which includes weakly venomous, back-fanged representatives (19) .
From the medical point of view, vipers, with their highly sophisticated venom delivery system, are the most important snakes in Arabia since they are responsible for most of the snakebites affecting humans, and the sand viper (Cerastes cerastes gasperettii) is the most frequent of all (20) .
Vipers are widely distributed throughout Africa and Eurasia, including Senegal in West Africa, North Africa, South Africa, Kenya in the East-Central Africa, and also Turkmenistan, Uzbekistan, Aral Sea, and Sri Lanka in the Indian subcontinent (15, 20, 54) . Cerastes cerastes mainly inhabits the North Africa (Algeria, Sudan, Chad and Sinai), and also Asia (Palestine, Jordan, Iraq and Iran). It is largely distributed in Arabia, except for areas of more than 1,500m in height (20) . According to the records of the Ministry of Health, the incidence of snakebites in Saudi Arabia is approximately 2,494 cases per year.
Following envenoming, spread of the various venom components depends to a large extent on their molecular weights. Thus, Reid and Theakston (44) showed that most constituents of viper venoms have high molecular weights and are slowly absorbed by the lymphatic system to produce maximum serum levels within 6-24 hours.
Pathophysiological picture after viper envenomation includes systemic and local effects. Local manifestations are mainly represented by edema, pain, hemorrhage and necrosis, which may result in prolonged or permanent disability (54) .
True vipers of the Old World and pit vipers of the New World present venoms rich in proteolytic enzymes. Many coagulant and anticoagulant factors like ancrod, crotalase, batroxobin, and α and β-fibrinogenases have been isolated and purified from their venoms (14, 25, 36, 42, 47, 57) . Knowledge on modulators of the coagulation factors of venoms from the Cerastes genus is scarce; however, Mohamed et al. (40) , studying Cerastes cerastes, which is homologous to the recently classified species Cerastes gasperettii from the Arabian Peninsula, referred to the existence of a factor with a thrombin-like coagulant effect. Later, Mohamed and El-Damarawy (39) showed that the venoms of two species (Cerastes and Vipera) of the genus Cerastes do possess fibrinogenolytic and fibrinolytic activities. Labib et al. (31) found out that some venom fractions of these two species were procoagulant at low concentrations and anticoagulant at high concentrations.
Several researchers have studied the biochemical and pharmacological effects of venoms collected from various vipers (38, 49, 50, 51) . However, to the best of our knowledge, the inflammatory effects of the venom from Cerastes gasperettii, especially those inhabiting the Arabian Peninsula, have not been investigated so far.
The present study reflected the dose and time-related inflammatory effects of CgV using the rat paw edema model and aimed to examine the capability of CgV to induce paw edema in rats and the employment of various drugs that could neutralize it and unveil the pharmacological mechanisms underlying these effects.
MATERIALS AND METHODS

Reagents
Cyproheptadine and dexamethasone were purchased from Merck & Co., Inc. (USA), and aprotinin from Buyer AG (Germany). Mepyramine, diclofenac, dipyridamole, and 
Venom and antivenom
Cerastes gasperettii venom (CgV) was obtained from the National Serpentarium, Riyadh, Saudi Arabia. It was dissolved in saline and stored at -20°C until used. Monospecific antivenom was raised in rabbits and was produced in our laboratory.
Measurement of rat paw edema
Male Wistar rats weighing 170-190g (mean weight = 180 g) were used for all the experiments and were provided by the Armed Forces Hospital, Research Center (Animal House Services), Riyadh, Saudi Arabia. All experiments were carried out according to the methods described by Faria et al. (14) and Al Asmari (3, 4 Basile, Italy). Results of the dose-dependent edema measurements were expressed as mean differences between the volumes of pre and post injected paws. Such measurements were carried out in order to determine the minimum edematous CgV dose that could produce the highest edema level (plateau). To determine the time the edema took to achieve its peak and consequently subside, measurements were performed at 0.25, 1, 2, 4, 6, and 24 h after venom injection.
Influence of various substances on CgV-induced edema
In another set of experiment, drugs were titrated to determine their minimim 
Statistical analysis
Data were presented as means ± SEM and were analyzed by ANOVA (GraphPad Instat and Prism Programs) followed by the Dunnett's Multiple Comparison Tests.
Values of p<0.05 were considered significant (99% confidence interval).
RESULTS
Effect of Cerastes gasperettii venom on rat paw edema
Heated CgV (3.75-240 µg/paw) induced dose ( Figure 1A ) and time-dependent ( Figure 1B ) non-hemorrhagic edema. The minimum edematous CgV dose that induced the highest edema level was 120 µg/paw ( Figure 1A ). Maximal timedependent response was observed 2h after venom injection, gradually decreasing from 4 to 6h and subsiding after 24h ( Figure 1B ). According to these results, the dose of 120 µg/paw was routinely used for all further experiments.
Pharmacological modulation of heated Cerastes gasperettii venom on rat paw induced edema
All drugs used were titrated against 120µg/paw heated CgV and the minimum effective dose that induced the maximum edema decrease (% inhibition) was determined ( Table 1) .
Comparative analysis of drugs and antivenoms inhibitory effect
The minimum effective dose of all the tested drugs and antivenoms was highly (p<0.001) significant in inhibiting CgV-induced edema compared with the positive control ( Figure 1A shows that the intensity of edema increases with increasing venom doses from 3.75 µg to 240 µg/paw. Each column represents mean ± SEM of six rats. * p<0.05, ** p<0.01, ***p<0.001, compared with saline. Figure 1B shows the time-dependent edema (from 0.25 to 24h) using 120 µg/paw of venom (---▲---), compared with saline (-■-). (41), nephrotoxicity (28) and cytotoxicity (10) .
The present study shows that subplantar injection of heated CgV in rats caused a significant paw edema similar to that induced by other viper venoms, which altered the vascular permeability in mice hind paws (13, 53) , causing abundant leukocyte infiltration, and hemorrhage with higher venom doses (13) . Since hemorrhage has been reported to appear soon after venom injection and to interfere with the inflammatory edema development (8, 14) , in our study we employed heated venom in all the tests. To further understand the pharmacological mechanisms involved in the CgV-induced rat paw edema, we used different treatments.
Although all the tested drugs and antivenoms were statistically significant and effective, there were variations in their efficiency. The drugs cyproheptadine and 5-nitroindazole were the most effective in reducing edema, confirming their important roles in in vivo mast cell degranulation (12, 14) and in the increase of cytokine production (27) .
Cyproheptadine leads to blockade of serotonin receptors; similarly methysergide was reported to decrease the edematogenic effects of many phlogistic agents such as sephadex (18) (45) and cytokine production (27) . Nitric oxide has been shown to play a very important role in edema induced by carrageenin in rats (26, 32, 45) and mice (27) . In rats, NO was involved in the acute inflammatory response following subplantar injection of bradykinin and serotonin (21) . It was also involved in neurogenic inflammation induced by topical application of mustard oil on rat skin (32) .
The present results also demonstrated that NO might play a role in reducing CgV- Mepyramine action is a second confirmation of the histamine release due to CgV.
Dipyridamole is a potent inhibitor of platelet aggregation and suppresses adenosine cellular uptake by erythrocytes. It is also responsible for the inhibition of phosphodiesterase (PDE), which, together with several other effects on other mediators responsible for inflammation induction, may reduce edema (58) .
The third most effective drugs in inhibiting edema were diclofenac, N ω -nitro-Larginine and quinacrine, another NOs inhibitor that confirmed the specificity of CgV in inducing edema. Inhibition of PLA 2 by quinacrine is a significant marker of induction of this mediator. Antagonists of the arachidonic acid metabolism such as cyclooxygenase and corticosteroids were shown to reduce edema induced by toxic proteins isolated from some insects (16, 24) . The present results demonstrated the possible involvement of NOs, PLA 2 and arachidonate metabolites in the edema formation, since antagonistic drugs (the third most effective group) also reduced rat paw volume.
The fourth most effective drugs included aprotinin, dexamethasone and NDGA.
Significant reduction of venom-induced paw edema by dexamethasone was expected since corticosteroids were known to indirectly inhibit PLA 2 action (17). Furthermore, corticosteroids directly acted on leucocytes and other cell types inhibiting the release of cytokines and other inflammatory mediators (5) . Similar actions were observed in the kinetics and cell composition of the inflammatory infiltrate in rat paw (23, 34) .
Aprotinin inhibits many proteases such as kallikrein, whose products, bradykinin and kallidin, are active inflammatory inducers (16, 22) . These kinins are potent vasodilators that increase the capillary permeability and are easily produced in tissues after injury; thus, being cardinal agents in the edema formation (22, 30) . The primary difference between the present findings and those of De Faria et al. (14) was that CgV induced significant edema without the need of potentiators. Secondly, NDGA and dexamethasone reduced CgV-induced edema, which indicated that these drugs might be involved in blocking or reducing mast cell degranulation and activation by CgV. Furthermore, H 1 and serotonin 5-HT 2 receptor antagonists significantly reduced CgV-induced rat paw edema. Contradictory results were obtained with other venoms (13, 43, 53) .
In conclusion, CgV induced edema 15 min after venom injection; peak volume was achieved after 2 h, which diminished and ceased within 24 h. There is release of active amines such as serotonin, histamine, arachidonic acid metabolites and NO at the injection site, since antagonistic drugs like cyproheptadine, mepyramine, NDGA, dexamethasone and NOs inhibitors reduced the edematogenic response at various doses. As cyproheptadine and 5-nitroindazole were the most active inhibitors of paw edema formation, we could suggest that at least serotonin, histamine and nNOs are important mediators and of high priority in edema induced by CgV.
